Palvella Therapeutics Awarded Up to $2.6 million Grant from the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development
Sagesse Bio Accelerates Development of SGY-101 into clinical development for Targeted Fat Reduction in Aesthetic Medicine and Medical Dermatology
Gore Range Capital Partners with Sirnaomics to Create Sagesse Bio to Advance RNAi Therapeutics for Focal Fat Reduction and Aesthetic Body Contouring
Avive Solutions Raises $56.5M
Dr. Balaji Jothishankar Joins Gore Range Capital as Entrepreneur in Residence
Novaestiq Unveils Platform of Innovations; Poised to Disrupt the US Aesthetic Market
AOA Dx News Exclusive: Liquid-biopsy startup closes $17M to fund ovarian cancer diagnostic test
Palvella Therapeutics Announces Series D Financing of Up to $37.7 Million
Financial Expert, Charmaine Tang, joins Gore Range Capital as Industry Advisor
Renowned Dermatologist - Dr. Matt Leavitt joins Gore Range Capital as an Executive Partner
Gore Range Capital Congratulates Dr. Seemal Desai, 2024 President of the AAD
Evommune Wins Gore Range Capital Skin Health Innovation Competition